Form 4: Nuvation Bio Director Acquires Stock Options

Nuvation Bio Inc. reports that Director Robert Mashal acquired stock options for 123,397 shares of Class A Common Stock.

Summary

• Director Robert Mashal acquired stock options for 123,397 shares of Nuvation Bio Inc. Class A Common Stock.
• The transaction occurred on May 21, 2026.
• The stock options have an exercise price of $4.79.
• The options are set to expire on May 20, 2036.
• Vesting is scheduled for the one-year anniversary of the grant date (May 21, 2026) or the next shareholder annual meeting, contingent on continuous service.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard insider transaction (grant of options) rather than a significant financial event or strategic shift.

Positives

• Director Robert Mashal's acquisition of stock options indicates a commitment to the company's future performance.
• The exercise price of $4.79 suggests a potential for significant upside if the stock price increases.

Risks

• The value of the stock options is directly tied to the future performance of Nuvation Bio Inc.'s stock price.
• If the company's stock price does not exceed the exercise price of $4.79, the options may not be exercised profitably.

Future Outlook

The vesting schedule for the stock options is tied to the one-year anniversary of the grant date or the next shareholder annual meeting, indicating a medium-term outlook for the realization of these options, contingent on continued service.

Industry Context

StockSavvy.ai notes that the acquisition of stock options by a director is a common practice in the biotechnology sector, often used as an incentive to align management's interests with those of shareholders and to retain key personnel.

Stakeholder Impact

• Shareholders: The acquisition of options by a director may be viewed positively as it aligns director incentives with stock performance, but the actual impact depends on future stock price movements.
• Employees: The vesting schedule tied to continuous service reinforces the importance of employee retention for the company's success.
• Management: The option grant serves as a performance incentive for the director.

Next Steps

• Continuous service by Robert Mashal through the applicable vesting dates.
• Potential exercise of stock options if the stock price exceeds the exercise price by the expiration date.

Key Dates

Keywords

Nuvation Bio Inc., NUVB, Form 4, Stock Options, Director, Beneficial Ownership, Securities Exchange Act, Insider Trading